288-TP-200/CF-Recombinant Human Thrombopoietin and 4 more items

Virginia Polytechnic Institute and State University awarded contract A208_P4834660 to Bio-Techne Sales Corporation on September 2, 2026, with a cumulative contract value of $5,131.10. The contract involves the procurement of five recombinant human protein products, all delivered to Nalluri Divyasri at Virginia Tech. The line items include Recombinant Human Thrombopoietin ($1,227.85), Recombinant Human Flt-3 ($1,380.60), Recombinant Human Vascular Endothelial Growth Factor 165 Protein ($1,079.65), Recombinant Human Stem Cell Factor Protein ($1,221.35), and Recombinant Human Fibroblast Growth Factor Basic/FGF2 ($221.65).

These biological research materials are standard reagents used in life sciences research applications. Each product line item represents a single unit purchase, with all materials designated for delivery to the same recipient within Virginia. The contract does not specify an explicit performance period or annual value breakdown, though the award date establishes the contract initiation as September 2, 2026. The relatively modest total contract value reflects the specialized nature of these research-grade biological products typically used in academic and institutional research settings.